AbbVie has announced the approval of Aquipta (atogepant) by the European Commission for the preventive treatment of migraine in adults...

Recent data reveals that advances in NHS treatment have substantially improved the survival rates of babies born with spinal muscular...

EiSai and Biogen announced that Biologics License Application (BLA) for lecanemab received Priority Review in China. The National Medical...

October 10, 2022 UCB plans to release Briviact in Japan with an Asian study UCB announced the Phase 3 study results of Briviact...

October 12, 2022 AstraZeneca announced strong efficacy data of Ultomiris. AstraZeneca announced the results of the CHAMPION-NMOSD trial...